Sean A. McCarthy, CEO of CytomX Therapeutics CTMX, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $1.2M. The latest trade was on 03/17.

SM

SM

Sean A. McCarthy

CEO

Company

CytomX Therapeutics CTMX

First filing

23/02/06

Trades

34 trades

Buys / sales

0 / 9

12-month net buying

−$1.2M

Last trade

03/17

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
CytomX TherapeuticsCTMX	Open-market sale10b5-1 plan	03/17	03/19	118,969 sh	$6.42	$763,780.98	−9.9%
CytomX TherapeuticsCTMX	Open-market sale10b5-1 plan	25/11/06	25/11/10	101,793 sh	$4.54	$462,140.22	−9.3%
CytomX TherapeuticsCTMX	Open-market sale	25/06/16	25/06/17	55,511 sh	$2.69	$149,324.59	−4.8%
CytomX TherapeuticsCTMX	Open-market sale	25/03/18	25/03/20	37,656 sh	$0.60	$22,593.6	−3.6%
CytomX TherapeuticsCTMX	Open-market sale	24/08/20	24/08/22	13,898 sh	$1.23	$17,094.54	−2.1%
CytomX TherapeuticsCTMX	Open-market sale	24/03/19	24/03/21	20,223 sh	$2.09	$42,266.07	−3.7%
CytomX TherapeuticsCTMX	Open-market sale	23/12/20	23/12/22	13,551 sh	$1.38	$18,700.38	−2.9%
CytomX TherapeuticsCTMX	Open-market sale	23/09/22	23/09/22	14,601 sh	$1.30	$18,981.3	−3.3%
CytomX TherapeuticsCTMX	Open-market sale	23/03/16	23/03/20	7,121 sh	$1.88	$13,387.48	−1.8%